[Federal Register Volume 68, Number 138 (Friday, July 18, 2003)]
[Rules and Regulations]
[Page 42589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18161]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522


Implantation or Injectable Dosage Form New Animal Drugs; Change 
of Sponsor; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of June 10, 2003 (68 FR 
34533). The document amended the animal drug regulations to reflect a 
change of sponsor for two approved new animal drug applications (NADAs) 
from Anthony Products Co. to Cross Vetpharm Group Ltd. The document was 
published with an error. This document corrects that error.

EFFECTIVE DATE: July 18, 2003.

FOR FURTHER INFORMATION CONTACT: Joyce A. Strong, Office of Policy (HF-
27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-827-7010.

SUPPLEMENTARY INFORMATION: In the FR Doc. 03-14547, appearing on page 
34533 in the Federal Register of Tuesday, June 10, 2003, the following 
correction is made:


Sec.  522.1696b  [Corrected]

0
1. On page 34534, in the second column, the last line in the amendatory 
language for Sec.  522.1696b Penicillin G procaine aqueous suspension 
is corrected to read ``010515, 053501, 059130, and 61623''.

    Dated: July 7, 2003.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 03-18161 Filed 7-17-03; 8:45 am]
BILLING CODE 4160-01-S